lifestyle.buyersdesire.org

Author: CARIS MPI, INC., d/b/a CARIS LIFE SCIENCES

Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients

March 20, 2026
Caris Life Sciences Introduces Powerful New Caris AI Insights to Identify Early Platinum Resistance in Ovarian Cancer

March 16, 2026
Caris Life Sciences to Showcase Five Studies at the 2026 USCAP Annual Meeting

March 14, 2026
Caris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic Cancer

March 14, 2026
Caris Launches Proprietary AI Insights Signature Which Deepens Understanding of Response to Breast Cancer Patients’ Oral Chemotherapy Drug

March 11, 2026
Caris Life Sciences to Participate in the TD Cowen 46th Annual Health Care Conference

March 11, 2026
Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26

March 9, 2026
Caris Life Sciences’ Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan

January 28, 2026
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results

January 12, 2026
Caris Life Sciences Partners with Everlywell to Launch Caris’ Forthcoming MCED Assay, Caris Detect

January 12, 2026